The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies

详细信息    查看全文

• 作者：Stéphane Cauchi (1)
  Kevin T Nead (1)
  Hélène Choquet (1)
  Fritz Horber (2)
  Natascha Potoczna (2)
  Beverley Balkau (3) (4)
  Michel Marre (5)
  Guillaume Charpentier (6)
  Philippe Froguel (1) (7)
  David Meyre (1)
  
• 刊名：BMC Medical Genetics
• 出版年：2008
• 出版时间：December 2008
• 年：2008
• 卷：9
• 期：1
• 全文大小：593KB
• 参考文献：1. Stumvoll M, Goldstein BJ, van Haeften TW: Type 2 diabetes: principles of pathogenesis and therapy. / Lancet 2005,365(9467):1333-346. CrossRef
  2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. / Jama 2003,289(1):76-9. CrossRef
  3. Kahn SE, Hull RL, Utzschneider KM: Mechanisms linking obesity to insulin resistance and type 2 diabetes. / Nature 2006,444(7121):840-46. CrossRef
  4. McAteer JB, Prudente S, Bacci S, Lyon HN, Hirschhorn JN, Trischitta V, Florez JC: The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects. / Diabetes 2008,57(4):1125-130. CrossRef
  5. Grarup N, Urhammer SA, Ek J, Albrechtsen A, Glumer C, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O: Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. / Diabetologia 2006,49(9):2097-104. CrossRef
  6. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Lepretre F, Dupont S, Hara K, Clement K, Bihain B, Kadowaki T, Froguel P: Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. / Hum Mol Genet 2002,11(21):2607-614. CrossRef
  7. Cauchi S, Choquet H, Gutierrez-Aguilar R, Capel F, Grau K, Proenca C, Dina C, Duval A, Balkau B, Marre M, Potoczna N, Langin D, Horber F, Sorensen TI, Charpentier G, Meyre D, Froguel P: Effects of TCF7L2 Polymorphisms on Obesity in European Populations. / Obesity (Silver Spring) 2008,16(2):476-82. CrossRef
  8. Meyre D, Bouatia-Naji N, Tounian A, Samson C, Lecoeur C, Vatin V, Ghoussaini M, Wachter C, Hercberg S, Charpentier G, Patsch W, Pattou F, Charles MA, Tounian P, Clement K, Jouret B, Weill J, Maddux BA, Goldfine ID, Walley A, Boutin P, Dina C, Froguel P: Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. / Nat Genet 2005,37(8):863-67. CrossRef
  9. Vasseur F, Helbecque N, Lobbens S, Vasseur-Delannoy V, Dina C, Clement K, Boutin P, Kadowaki T, Scherer PE, Froguel P: Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. / Diabetologia 2005,48(5):892-99. CrossRef
  10. Bochenski J, Placha G, Wanic K, Malecki M, Sieradzki J, Warram JH, Krolewski AS: New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. / Diabetes 2006,55(9):2626-630. CrossRef
  11. Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clement K, Charles MA, Tauber M, Weill J, Froguel P: Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. / BMC Med Genet 2005, 6:11. CrossRef
  12. Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, Hamman RF, Knowler WC, Nathan DM, Altshuler D: Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. / J Clin Endocrinol Metab 2007,92(4):1502-509. CrossRef
  13. Ludovico O, Pellegrini F, Di Paola R, Minenna A, Mastroianno S, Cardellini M, Marini MA, Andreozzi F, Vaccaro O, Sesti G, Trischitta V: Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk. / Obesity (Silver Spring) 2007,15(5):1076-081. CrossRef
  14. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J: A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. / Nat Genet 1998,20(3):284-87. CrossRef
  15. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. / Nat Med 2001,7(8):941-46. CrossRef
  16. Maddux BA, Goldfine ID: Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. / Diabetes 2000,49(1):13-9. CrossRef
  17. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, Sjogren M, Ling C, Eriksson KF, Lethagen AL, Mancarella R, Berglund G, Tuomi T, Nilsson P, Del Prato S, Groop L: Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. / J Clin Invest 2007,117(8):2155-163. CrossRef
  18. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. / Nature 2001,409(6818):307-12. CrossRef
  19. Nielsen EM, Hansen L, Carstensen B, Echwald SM, Drivsholm T, Glumer C, Thorsteinsson B, Borch-Johnsen K, Hansen T, Pedersen O: The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. / Diabetes 2003,52(2):573-77. CrossRef
  20. Lehto M, Bitzen PO, Isomaa B, Wipemo C, Wessman Y, Forsblom C, Tuomi T, Taskinen MR, Groop L: Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism. / Diabetes 1999,48(2):423-25. CrossRef
  21. Johansson S, Raeder H, Eide SA, Midthjell K, Hveem K, Sovik O, Molven A, Njolstad PR: Studies in 3,523 Norwegians and meta-analysis in 11,571 subjects indicate that variants in the hepatocyte nuclear factor 4 alpha (HNF4A) P2 region are associated with type 2 diabetes in Scandinavians. / Diabetes 2007,56(12):3112-117. CrossRef
  22. Holmkvist J, Cervin C, Lyssenko V, Winckler W, Anevski D, Cilio C, Almgren P, Berglund G, Nilsson P, Tuomi T, Lindgren CM, Altshuler D, Groop L: Common variants in HNF-1 alpha and risk of type 2 diabetes. / Diabetologia 2006,49(12):2882-891. CrossRef
  23. Terauchi Y, Takamoto I, Kubota N, Matsui J, Suzuki R, Komeda K, Hara A, Toyoda Y, Miwa I, Aizawa S, Tsutsumi S, Tsubamoto Y, Hashimoto S, Eto K, Nakamura A, Noda M, Tobe K, Aburatani H, Nagai R, Kadowaki T: Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. / J Clin Invest 2007,117(1):246-57. CrossRef
  24. Velho G, Froguel P, Clement K, Pueyo ME, Rakotoambinina B, Zouali H, Passa P, Cohen D, Robert JJ: Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. / Lancet 1992,340(8817):444-48. CrossRef
  25. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, Baker A, Snorradottir S, Bjarnason H, Ng MC, Hansen T, Bagger Y, Wilensky RL, Reilly MP, Adeyemo A, Chen Y, Zhou J, Gudnason V, Chen G, Huang H, Lashley K, Doumatey A, So WY, Ma RC, Andersen G, Borch-Johnsen K, / et al.: A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. / Nat Genet 2007,39(6):770-75. CrossRef
  26. Osawa H, Yamada K, Onuma H, Murakami A, Ochi M, Kawata H, Nishimiya T, Niiya T, Shimizu I, Nishida W, Hashiramoto M, Kanatsuka A, Fujii Y, Ohashi J, Makino H: The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. / Am J Hum Genet 2004,75(4):678-86. CrossRef
  27. van Dam RM, Hoebee B, Seidell JC, Schaap MM, de Bruin TW, Feskens EJ: Common variants in the ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses. / Diabet Med 2005,22(5):590-98. CrossRef
  28. Weedon MN, Owen KR, Shields B, Hitman G, Walker M, McCarthy MI, Love-Gregory LD, Permutt MA, Hattersley AT, Frayling TM: Common variants of the hepatocyte nuclear factor-4alpha P2 promoter are associated with type 2 diabetes in the U.K. population. / Diabetes 2004,53(11):3002-006. CrossRef
  29. Winckler W, Burtt NP, Holmkvist J, Cervin C, de Bakker PI, Sun M, Almgren P, Tuomi T, Gaudet D, Hudson TJ, Ardlie KG, Daly MJ, Hirschhorn JN, Altshuler D, Groop L: Association of common variation in the HNF1alpha gene region with risk of type 2 diabetes. / Diabetes 2005,54(8):2336-342. CrossRef
  30. Winckler W, Weedon MN, Graham RR, McCarroll SA, Purcell S, Almgren P, Tuomi T, Gaudet D, Bostrom KB, Walker M, Hitman G, Hattersley AT, McCarthy MI, Ardlie KG, Hirschhorn JN, Daly MJ, Frayling TM, Groop L, Altshuler D: Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes. / Diabetes 2007,56(3):685-93. CrossRef
  31. Balkau B: [An epidemiologic survey from a network of French Health Examination Centres, (D.E.S.I.R.): epidemiologic data on the insulin resistance syndrome]. / Rev Epidemiol Sante Publique 1996,44(4):373-75.
  32. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P: A genome-wide association study identifies novel risk loci for type 2 diabetes. / Nature 2007,445(7130):881-85. CrossRef
  33. Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG, Frazer KA, Cox DR: Whole-genome patterns of common DNA variation in three human populations. / Science 2005,307(5712):1072-079. CrossRef
  34. Branson R, Potoczna N, Kral JG, Lentes KU, Hoehe MR, Horber FF: Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. / N Engl J Med 2003,348(12):1096-103. CrossRef
  35. Silander K, Mohlke KL, Scott LJ, Peck EC, Hollstein P, Skol AD, Jackson AU, Deloukas P, Hunt S, Stavrides G, Chines PS, Erdos MR, Narisu N, Conneely KN, Li C, Fingerlin TE, Dhanjal SK, Valle TT, Bergman RN, Tuomilehto J, Watanabe RM, Boehnke M, Collins FS: Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. / Diabetes 2004,53(4):1141-149. CrossRef
  36. Dahlgren A, Zethelius B, Jensevik K, Syvanen AC, Berne C: Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men. / Diabetologia 2007.
  37. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA: Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. / Diabetes 2002,51(6):1884-888. CrossRef
  38. Kubaszek A, Pihlajamaki J, Karhapaa P, Vauhkonen I, Laakso M: The K121Q polymorphism of the PC-1 gene is associated with insulin resistance but not with dyslipidemia. / Diabetes Care 2003,26(2):464-67. CrossRef
  39. Bacci S, Ludovico O, Prudente S, Zhang YY, Di Paola R, Mangiacotti D, Rauseo A, Nolan D, Duffy J, Fini G, Salvemini L, Amico C, Vigna C, Pellegrini F, Menzaghi C, Doria A, Trischitta V: The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction. / Diabetes 2005,54(10):3021-025. CrossRef
  40. Weedon MN, Shields B, Hitman G, Walker M, McCarthy MI, Hattersley AT, Frayling TM: No evidence of association of ENPP1 variants with type 2 diabetes or obesity in a study of 8,089 U.K. Caucasians. / Diabetes 2006,55(11):3175-179. CrossRef
  41. Alvarsson M, Wajngot A, Cerasi E, Efendic S: K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 years. / Diabetologia 2005,48(11):2262-268. CrossRef
  42. Watanabe RM, Allayee H, Xiang AH, Trigo E, Hartiala J, Lawrence JM, Buchanan TA: Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans. / Diabetes 2007,56(5):1481-485. CrossRef
  43. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. / Diabetes 2003,52(1):102-10. CrossRef
  44. Larsson H, Ahren B: Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. / Diabetes Care 2000,23(5):650-57. CrossRef
  45. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. / Diabetes 1997,46(1):3-0. CrossRef
  46. Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. / Nature 2001,414(6865):799-06. CrossRef
  47. Prentki M, Nolan CJ: Islet beta cell failure in type 2 diabetes. / J Clin Invest 2006,116(7):1802-812. CrossRef
  48. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. / N Engl J Med 1993,329(27):1988-992. CrossRef
  49. Garg A: Lipodystrophies. / Am J Med 2000,108(2):143-52. CrossRef
  50. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S: Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. / Nature 1999,402(6764):880-83.
  51. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. / Nat Med 2002,8(11):1288-295. CrossRef
  52. Liang J, Fu M, Ciociola E, Chandalia M, Abate N: Role of ENPP1 on adipocyte maturation. / PLoS ONE 2007,2(9):e882. CrossRef
  53. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/9/45/prepub
  
• 作者单位：Stéphane Cauchi (1)
  Kevin T Nead (1)
  Hélène Choquet (1)
  Fritz Horber (2)
  Natascha Potoczna (2)
  Beverley Balkau (3) (4)
  Michel Marre (5)
  Guillaume Charpentier (6)
  Philippe Froguel (1) (7)
  David Meyre (1)
  
  1. CNRS UMR8090, Institut de Biologie de Lille, Génomique et Physiologie Moléculaire des Maladies Métaboliques, Lille, France
  2. Department of Surgery and Internal Medicine, Hirslanden Clinics, Bern and Zurich, Switzerland
  3. INSERM U780-IFR69, H?pital Paul Brousse, Villejuif, France
  4. Université Paris-Sud, Paris, France
  5. INSERM U695, H?pital Bichat, Paris, France
  6. H?pital de Corbeil, service d'endocrinologie et de diabétologie, Corbeil-Essonnes, France
  7. Genomic Medicine, Hammersmith Hospital, Imperial College London, UK
  
• ISSN：1471-2350

文摘

Background Considering that a portion of the heterogeneity amongst previous replication studies may be due to a variable proportion of obese subjects in case-control designs, we assessed the association of genetic variants with type 2 diabetes (T2D) in large groups of obese and non-obese subjects. Methods We genotyped RETN, KCNJ11, HNF4A, HNF1A, GCK, SLC30A8, ENPP1, ADIPOQ, PPARG, and TCF7L2 polymorphisms in 1,283 normoglycemic (NG) and 1,581 T2D obese individuals as well as in 3,189 NG and 1,244 T2D non-obese subjects of European descent, allowing us to examine T2D risk over a wide range of BMI. Results Amongst non-obese individuals, we observed significant T2D associations with HNF1A I27L [odds ratio (OR) = 1.14, P = 0.04], GCK -30G>A (OR = 1.23, P = 0.01), SLC30A8 R325W (OR = 0.87, P = 0.04), and TCF7L2 rs7903146 (OR = 1.89, P = 4.5 × 10-23), and non-significant associations with PPARG Pro12Ala (OR = 0.85, P = 0.14), ADIPOQ -11,377C>G (OR = 1.00, P = 0.97) and ENPP1 K121Q (OR = 0.99, P = 0.94). In obese subjects, associations with T2D were detected with PPARG Pro12Ala (OR = 0.73, P = 0.004), ADIPOQ -11,377C>G (OR = 1.26, P = 0.02), ENPP1 K121Q (OR = 1.30, P = 0.003) and TCF7L2 rs7903146 (OR = 1.30, P = 1.1 × 10-4), and non-significant associations with HNF1A I27L (OR = 0.96, P = 0.53), GCK -30G>A (OR = 1.15, P = 0.12) and SLC30A8 R325W (OR = 0.95, P = 0.44). However, a genotypic heterogeneity was only found for TCF7L2 rs7903146 (P = 3.2 × 10-5) and ENPP1 K121Q (P = 0.02). No association with T2D was found for KCNJ11, RETN, and HNF4A polymorphisms in non-obese or in obese individuals. Conclusion Genetic variants modulating insulin action may have an increased effect on T2D susceptibility in the presence of obesity, whereas genetic variants acting on insulin secretion may have a greater impact on T2D susceptibility in non-obese individuals.